Division of Endocrinology, Diabetes, and Metabolism — Los Angeles, California

Division of Endocrinology, Diabetes, and Metabolism is a clinical research site located in Los Angeles, California, United States 90027.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Division of Endocrinology, Diabetes, and Metabolism has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Type 2 Diabetes.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Division of Endocrinology, Diabetes, and Metabolism?

Division of Endocrinology, Diabetes, and Metabolism has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Division of Endocrinology, Diabetes, and Metabolism conducted?

Division of Endocrinology, Diabetes, and Metabolism has 2 clinical trials on record, with 1 currently active. Their work covers Type 2 Diabetes.

Is Division of Endocrinology, Diabetes, and Metabolism accredited by Crixeo Health?

Division of Endocrinology, Diabetes, and Metabolism has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Division of Endocrinology, Diabetes, and Metabolism?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.